|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
1996-7-17
|
|
pubmed:abstractText |
Most patients with esophageal carcinoma present with locally advanced disease and a poor prognosis. Surgery or radiation provides palliation for locally advanced esophageal carcinoma. The role of neoadjuvant therapy remains to be defined. We administered neoadjuvant chemotherapy consisting of 5-fluorouracil (5-FU), leucovorin, interferon-alpha, and cisplatin to 11 patients with locally advanced disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
77
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2432-9
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8640689-Adult,
pubmed-meshheading:8640689-Aged,
pubmed-meshheading:8640689-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8640689-Carcinoma,
pubmed-meshheading:8640689-Chemotherapy, Adjuvant,
pubmed-meshheading:8640689-Cisplatin,
pubmed-meshheading:8640689-Combined Modality Therapy,
pubmed-meshheading:8640689-Esophageal Neoplasms,
pubmed-meshheading:8640689-Female,
pubmed-meshheading:8640689-Fluorouracil,
pubmed-meshheading:8640689-Humans,
pubmed-meshheading:8640689-Immunotherapy,
pubmed-meshheading:8640689-Interferon-alpha,
pubmed-meshheading:8640689-Leucovorin,
pubmed-meshheading:8640689-Male,
pubmed-meshheading:8640689-Middle Aged,
pubmed-meshheading:8640689-Recombinant Proteins,
pubmed-meshheading:8640689-Survival Analysis
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Phase II trial of 5-fluorouracil, leucovorin, interferon-alpha-2a, and cisplatin as neoadjuvant chemotherapy for locally advanced esophageal carcinoma.
|
|
pubmed:affiliation |
Surgery Branch, National Cancer Institute, Bethesda, Maryland 20892, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
